An alert to the review and implementation of homecare medicines and the associated implementation arrangements has been sent to NHS commissioners and providers. It highlights potential benefits delivered by acute trusts and commissioners working in partnership.
The benefits for organisations can include:
- improved internal governance arrangements
- protection of the statutory responsibilities of chief pharmacists for the supply and dispensing of homecare medicines in a treatment setting
- improved working with commissioners and individuals
- improved cost efficiency and savings from VAT and other supplier delivered benefits.
There is potential to further develop homecare medicines services. Read the letter from Mark Hackett, Chief Executive of University Hospital Southampton and the report achieving savings from high cost drugs